Search

Your search keyword '"Neoplasms chemistry"' showing total 1,890 results

Search Constraints

Start Over You searched for: Descriptor "Neoplasms chemistry" Remove constraint Descriptor: "Neoplasms chemistry"
1,890 results on '"Neoplasms chemistry"'

Search Results

1. Direct and Rapid Visualization of the Spatial Distribution of Cholesterol in Alzheimer's and Cancer Tissue via MALDI Mass Spectrometry Imaging.

2. cfOmics: a cell-free multi-Omics database for diseases.

3. CancerProteome: a resource to functionally decipher the proteome landscape in cancer.

4. Selective Photodynamic Activity of Tetrakis(4-aminophenyl)porphyrins with and without Acetyl Protecting Groups on Cancer and Normal Cells.

5. Renal Clearable Magnetic Nanoreporter for Colorimetric Urinalysis of Tumor.

6. Test of the FlashFREEZE unit in tissue samples freezing for biobanking purposes.

7. A Bio-Liposome Activating Natural Killer Cell by Illuminating Tumor Homogenization Antigen Properties.

8. A facile turn-on chemiluminescence probe for sensitive imaging on aminopeptidase N activity.

9. A β-hairpin peptide with pH-controlled affinity for tumor cells.

10. Thiol profiling in cancer cell lines by HPLC-mass spectrometry.

11. Assembling BH3-mimic peptide into a nanocluster to target intracellular Bcl2 towards the apoptosis induction of cancer cell.

12. Depletion of essential fatty acids in muscle is associated with shorter survival of cancer patients undergoing surgery-preliminary report.

13. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors.

14. PD-L1 immunostaining: what pathologists need to know.

15. TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response.

16. Analysis of the Electrophoretic Profiles of Prion Protein in Carcinous and Pericarcinous Lysates of Six Different Types of Cancers.

17. Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement.

18. IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.

19. Novel Perbutyrylated Glucose Derivatives of (-)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking.

20. Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis.

21. First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors.

22. Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors.

23. A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues.

24. Telepathology Practice in Cancer Diagnosis in Saint Jean de Dieu Hospital - Tanguieta, Benin.

25. Characterization of nanoparticles combining polyamine detection with photodynamic therapy.

26. RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site.

27. Selective recognition of tumor cells by molecularly imprinted polymers.

28. Confronting molecular rotors and self-quenched dimers as fluorogenic BODIPY systems to probe biotin receptors in cancer cells.

29. Design and synthesis of highly fluorescent and stable fullerene nanoparticles as probes for folic acid detection and targeted cancer cell imaging.

30. The impact of pre-analytical parameters on class II biomarkers by immunohistochemistry: concordance across four tissue processing protocols.

31. New insight into G-quadruplexes; diagnosis application in cancer.

32. Biomechanical Properties of Cancer Cells.

33. Replacing Molecular Genetic Testing With Immunohistochemistry Using Antibodies That Recognize the Protein Products of Gene Rearrangements: "Next-generation" Immunohistochemistry.

34. Potential impact of tissue molecular heterogeneity on ambient mass spectrometry profiles: a note of caution in choosing the right disease model.

35. Remodeling nanoDESI Platform with Ion Mobility Spectrometry to Expand Protein Coverage in Cancerous Tissue.

36. Raman Imaging: An Impending Approach Towards Cancer Diagnosis.

37. Novel Platinum(II) Complex-based Luminescent Probe for Detection of Hypochlorite in Cancer Cells.

38. Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.

39. Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.

40. The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

41. FO-SPR biosensor calibrated with recombinant extracellular vesicles enables specific and sensitive detection directly in complex matrices.

42. Amphiphilic fluorescent probe self-encored in plasma to detect pH fluctuations in cancer cell membranes.

43. Prognostic Value of Complement Properdin in Cancer.

44. Time-resolved non-invasive metabolomic monitoring of a single cancer spheroid by microfluidic NMR.

45. Peptide Blocking CTLA-4 and B7-1 Interaction.

46. Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.

47. Atomic force microscopy to elucidate how peptides disrupt membranes.

48. Recent advances in fluorescent probes for extracellular pH detection and imaging.

49. Assessing Impact of Platinum Complexes on Mitochondrial Functions.

50. From proteomic landscape to single-cell oncoproteomics.

Catalog

Books, media, physical & digital resources